Combination Therapy for Sleep Disturbance in Patients With Advanced Cancer
Phase 2/3
188
about 4.3 years
18+
1 site in TX
About this study
This trial is testing if a combination of treatments, including melatonin, methylphenidate, and/or bright light therapy (BLT), can improve sleep and related symptoms like fatigue, anxiety, and depression in people with advanced cancer. This is an investigational trial comparing these treatments to placebos.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo for Melatonin
- 2.Take Melatonin
- 3.Take Methylphenidate
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
melatonin (Hormone supplement; regulates sleep-wake cycle), methylphenidate (CNS stimulant; blocks reuptake of dopamine and norepinephrine)
oral (Disintegrating Oral Tablet)
Primary: Pittsburgh Sleep Quality Index (PSQI) questionnaires
Psychiatry / Mental Health, Oncology